Position in EOLS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$228,158
New position
Shares Held
55,513
first reported quarter
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 85%
Shared 0%
None 15%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026FULLER & THALER ASSET MANAGEMENT, INC. holds $650,343,348 across 12 Drug Manufacturers - Specialty & Generic names. EOLS ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
280,405 | $166,274,556 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
6,015,064 | $143,940,481 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
4,529,583 | $138,061,689 | |
| 4 | PRGO |
PERRIGO Co plc
|
7,662,883 | $82,299,363 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
1,499,584 | $49,591,242 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
1,419,677 | $29,472,494 | |
| 7 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
1,395,139 | $27,330,773 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
87,350 | $11,507,489 |
All Filings in EOLS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $228,158 | 55,513 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||